ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 71 filers reported holding ALLOVIR INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $887,475 | -21.1% | 412,779 | +24.8% | 0.00% | – |
| Q2 2023 | $1,124,985 | -6.1% | 330,878 | +8.8% | 0.00% | – |
| Q1 2023 | $1,198,497 | -23.0% | 304,187 | +0.2% | 0.00% | -100.0% |
| Q4 2022 | $1,556,796 | -34.0% | 303,469 | +1.5% | 0.00% | 0.0% |
| Q3 2022 | $2,360,000 | +177.3% | 299,060 | +37.1% | 0.00% | – |
| Q2 2022 | $851,000 | -38.6% | 218,134 | +6.3% | 0.00% | – |
| Q1 2022 | $1,385,000 | -48.7% | 205,124 | -1.6% | 0.00% | -100.0% |
| Q4 2021 | $2,698,000 | -47.3% | 208,437 | +2.1% | 0.00% | -50.0% |
| Q3 2021 | $5,116,000 | +82.2% | 204,147 | +43.5% | 0.00% | +100.0% |
| Q2 2021 | $2,808,000 | -16.1% | 142,216 | -0.5% | 0.00% | 0.0% |
| Q1 2021 | $3,345,000 | -23.2% | 142,934 | +26.1% | 0.00% | -50.0% |
| Q4 2020 | $4,358,000 | +44.8% | 113,360 | +3.6% | 0.00% | +100.0% |
| Q3 2020 | $3,010,000 | – | 109,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |